Meng-Xia Li Selected Research

Meng-Xia Li Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 12/2009
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 12/2009
4	Lung Neoplasms (Lung Cancer) 05/2012 - 01/2010
3	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 12/2007
2	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2015
2	Adenocarcinoma of Lung 01/2012 - 12/2009
2	Hypoxia (Hypoxemia) 01/2010 - 12/2007
1	Asphyxia (Suffocation) 10/2023
1	Anemia 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 06/2023
1	Triple Negative Breast Neoplasms 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Hypertrophy 01/2021
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2021
1	Papillary Adenocarcinoma 07/2020
1	Jaundice (Icterus) 07/2020
1	Pancreatic Fistula (Pancreatic Fistulas) 07/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Hyperandrogenism 09/2019
1	Hypertension (High Blood Pressure) 06/2019
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Rectal Neoplasms (Rectal Cancer) 03/2016
1	Carcinoma (Carcinomatosis) 03/2016
1	Pneumonia (Pneumonitis) 07/2014
1	Multiple Myeloma 10/2010
1	Prostatic Neoplasms (Prostate Cancer) 01/2010
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2010
1	Carcinogenesis 01/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2009

Drug/Important Bio-Agent (IBA)

6	EndonucleasesIBA 07/2014 - 12/2007
4	Proteins (Proteins, Gene)FDA Link 12/2011 - 12/2007
2	AndrogensIBA 01/2021 - 09/2019
2	AntigensIBA 12/2019 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 12/2009
2	EndostatinsIBA 11/2015 - 12/2007
2	GenisteinIBA 07/2014 - 01/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2012 - 01/2010
2	DNA-(Apurinic or Apyrimidinic Site) Lyase (AP Endonuclease)IBA 12/2011 - 12/2007
2	Small Interfering RNA (siRNA)IBA 12/2009 - 12/2007
1	C-Reactive ProteinIBA 10/2023
1	immune RNA (I-RNA)IBA 01/2022
1	olaparibIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Dihydrotestosterone (Androstanolone)IBA 01/2021
1	LipidsIBA 01/2021
1	CarbohydratesIBA 12/2019
1	BilirubinIBA 12/2019
1	AlbuminsIBA 12/2019
1	Alkaline PhosphataseIBA 12/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2019
1	Bile Acids and Salts (Bile Acids)IBA 12/2019
1	Fetal Proteins (Fetoprotein)IBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 06/2019
1	CholesterolIBA 06/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Gefitinib (Iressa)FDA Link 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	CytokinesIBA 07/2014
1	Tumor Biomarkers (Tumor Markers)IBA 01/2013
1	AutoantibodiesIBA 01/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012
1	Interleukin-8 (Interleukin 8)IBA 10/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2010
1	Interleukin-6 (Interleukin 6)IBA 10/2010
1	Transcription Factors (Transcription Factor)IBA 01/2010
1	Staphylococcal Protein A (Protein A)IBA 12/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2007
2	Neoadjuvant Therapy 01/2022 - 03/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2013
2	Photochemotherapy (Photodynamic Therapy) 05/2012 - 01/2010
1	Liver Transplantation 06/2023
1	Stents 07/2020
1	Adjuvant Chemotherapy 03/2016
1	Radiotherapy 01/2009